Drug Index(BETA)

Health Prior 21 is Asia’s first total health care solution Portal with 24 hour Health News and Health Care Management centre. Our aim is to reduce the sufferings of people as well as helping doctors & health care providers in South Asia with easy access to comprehensive information on health care initiatives around the world in order to make informed choices. HP21 Drug Index is a biannually published index of essential and up-to-date information on the selection, prescribing, dispensing and administration of medicines for doctors, pharmacists and other healthcare professionals. It is designed to be used as a handy & rapid reference for routine prescribing of pharmaceutical products available in Bangladesh. Information on drugs and advices published herein is prepared by our own professional editorial staff under guidance of advisors & expert clinicians from all therapeutic areas and is based on medical and pharmaceutical literature, manufacturers’ product literature, information from regulatory authorities & professional bodies and other approved official reference sources. HP21 Drug Index also followed authoritative national guidelines and emerging safety concerns.

HP21 Drug Index, especially older version, may not always include all the information necessary for prescribing and dispensing. So, it is vital to use the most recent edition for making clinical decisions and should not be relied upon solely for final treatment decisions. The editors, advisors and publisher also expressly disclaim any and all liability to any person whosoever in respect of any loss, damage, death, personal injury or other consequences whatsoever, howsoever caused or arising, suffered by any such person by their use of or reliance upon, in any way, the information contained in this publication. HP21 Drug Index should be interpreted in the light of professional knowledge and supplemented as necessary by specialized publications and by reference to the product literature.

HP21 website (www.healthprior21.com/drugindex) includes updated and additional information of relevance to healthcare professionals. Other digital formats of HP21 Drug Index including offline and mobile device versions are produced in parallel with the printed version. HP21 welcomes comments from all healthcare professionals. Comments, revision ideas and constructive criticisms should be emailed to info@healthprior21.com.